Vaso Corporation (VASO)
(Delayed Data from OTC)
$0.13 USD
0.00 (0.62%)
Updated Nov 6, 2024 01:37 PM ET
NA Value
NA Growth NA Momentum NA VGMPrice, Consensus and EPS Surprise
VASO 0.13 0.00(0.62%)
Will VASO be a Portfolio Killer in November?
Zacks Investment Research is releasing its prediction for VASO based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for VASO
The Zacks Analyst Blog Highlights Exxon Mobil, Mastercard, Procter & Gamble and Vaso
Top Research Reports for Exxon Mobil, Mastercard and Procter & Gamble
VASO: What are Zacks experts saying now?
Zacks Private Portfolio Services
VASO Q2 Earnings Flat Y/Y, Revenues Down, Gross Margin Contracts
Zacks Initiates Coverage of Vaso With Neutral Recommendation
The Zacks Analyst Blog Highlights SAP, Abbott Laboratories, Citigroup, Team and Vaso
Other News for VASO
Vaso announces termination of business combination with Achari Ventures Holdings Corp. I
Vaso Corporation Announces Termination of Business Combination Agreement with Achari Ventures Holdings Corp. I
Vaso Corporation Announces Date Change for Its Stockholders Meeting
Vasomedical reports Q2 results
Vaso Corporation Announces Financial Results for Second Quarter 2024